126 related articles for article (PubMed ID: 35511698)
1. Survival benefit of l-carnitine supplementation in patients with cirrhosis.
Miwa T; Hanai T; Nishimura K; Sakai Y; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1326-1334. PubMed ID: 35511698
[TBL] [Abstract][Full Text] [Related]
2. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis.
Tajiri K; Futsukaichi Y; Kobayashi S; Yasumura S; Takahara T; Minemura M; Sugiyama T
J Nutr Sci Vitaminol (Tokyo); 2018; 64(5):321-328. PubMed ID: 30381621
[TBL] [Abstract][Full Text] [Related]
3. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy.
Tani J; Morishita A; Sakamoto T; Takuma K; Nakahara M; Fujita K; Oura K; Tadokoro T; Mimura S; Nomura T; Yoneyama H; Kobara H; Himoto T; Masaki T
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):288-293. PubMed ID: 32925502
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis.
Hanai T; Shiraki M; Imai K; Suetugu A; Takai K; Shimizu M
Nutrients; 2020 Jun; 12(7):. PubMed ID: 32610446
[TBL] [Abstract][Full Text] [Related]
5. Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?
Hiraoka A; Kiguchi D; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):878-884. PubMed ID: 31150367
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
[TBL] [Abstract][Full Text] [Related]
8. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
Yoon EL; Ahn SB; Jun DW; Cho YK; Song DS; Jeong JY; Kim HY; Jung YK; Song MJ; Kim SE; Kim HS; Jeong SW; Kim SG; Lee TH
Korean J Intern Med; 2022 Jul; 37(4):757-767. PubMed ID: 35526858
[TBL] [Abstract][Full Text] [Related]
10. L-Carnitine in the treatment of mild or moderate hepatic encephalopathy.
Malaguarnera M; Pistone G; Astuto M; Dell'Arte S; Finocchiaro G; Lo Giudice E; Pennisi G
Dig Dis; 2003; 21(3):271-5. PubMed ID: 14571103
[TBL] [Abstract][Full Text] [Related]
11. Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients.
Shiraki M; Shimizu M; Moriwaki H; Okita K; Koike K
Hepatol Res; 2017 Mar; 47(4):321-327. PubMed ID: 27254133
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis.
Fujita M; Abe K; Hayashi M; Takahashi A; Ohira H
Medicine (Baltimore); 2020 Jul; 99(28):e21061. PubMed ID: 32664122
[TBL] [Abstract][Full Text] [Related]
13. Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta-analysis.
Abbasnezhad A; Choghakhori R; Kashkooli S; Alipour M; Asbaghi O; Mohammadi R
J Gastroenterol Hepatol; 2019 Dec; 34(12):2062-2070. PubMed ID: 31254469
[TBL] [Abstract][Full Text] [Related]
14. Effects of L-carnitine in patients with hepatic encephalopathy.
Malaguarnera M; Pistone G; Elvira R; Leotta C; Scarpello L; Liborio R
World J Gastroenterol; 2005 Dec; 11(45):7197-202. PubMed ID: 16437672
[TBL] [Abstract][Full Text] [Related]
15. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.
Shen YC; Chang YH; Fang CJ; Lin YS
Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342
[TBL] [Abstract][Full Text] [Related]
16. Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin.
Kubota K; Uojima H; Shao X; Iwasaki S; Hidaka H; Wada N; Nakazawa T; Shibuya A; Kako M; Koizumi W
Dig Dis; 2022; 40(3):313-321. PubMed ID: 34348263
[TBL] [Abstract][Full Text] [Related]
17. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Goh ET; Stokes CS; Sidhu SS; Vilstrup H; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 May; 5(5):CD012410. PubMed ID: 29762873
[TBL] [Abstract][Full Text] [Related]
18. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis.
Sato S; Namisaki T; Furukawa M; Saikawa S; Kawaratani H; Kaji K; Takaya H; Shimozato N; Sawada Y; Kitagawa K; Moriya K; Akahane T; Mitoro A; Hoki N; Ann T; Yoshiji H
Biomed Rep; 2020 Dec; 13(6):65. PubMed ID: 33149909
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.
Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y
J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
